Sign in
Enrolling by invitationNo phase

Ultrasound Checks of Stomach Contents in People Taking GLP-1 Medicines

Looks at stomach contents by ultrasound in people taking GLP-1 medicines for diabetes or obesity.

Key facts

Who runs it
Children's Hospital Medical Center, Cincinnati
Where
Cincinnati, United StatesSee the site
Trial code
Registry title
GLP_1 RA Ultrasound Study
Status
Enrolling by invitation
People taking part
100 people, planned
Started
8 Jul 2024
Planned end
Jul 2026
Type of study
Observational, 2 groups
Treatments tested
  • Glucagon-Like Peptide-1 receptor agonists
  • Point of Care Gastric Ultrasound
Record updated
7 November 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with type 2 diabetes and a body mass index over 35, some taking a GLP-1 RA drug and some not. It checks how much food is left in the stomach before surgery.

Age
10 Years to 25 Years
Sex
All sexes can join.
Disease stage
Type 2 diabetes with a body mass index over 35.
Earlier treatment
One group is currently taking a GLP-1 RA drug. The control group is not taking one.

Main reasons for not taking part

  • Diagnosis of gastroparesis
  • Previous gastric bypass or any other gastric surgery
  • Currently on peritoneal dialysis
  • Abdominal pathology or gastro-intestinal obstruction
  • Pregnancy

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Body Mass Index over 35
  • Type 2 Diabetes
  • Currently taking GLP01 RA agonist (for GLP 1 group)
  • Not taking GLP-1 RA agonist (for control group)

Who cannot take part

  • Previous gastric bypass or any other gastric surgery
  • Currently on peritoneal dialysis
  • Diagnosis of gastroparesis
  • patient refusal to participate
  • Abdominal pathology
  • Gastro-intestinal obstruction
  • Pregnancy

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 10 and 25 years old?

Where in United States

  • Cincinnati Children's HospitalCincinnati, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The purpose of the study is to determine whether patients taking GLP-1 RAs have increased residual (left behind), gastric (stomach), contents due to delayed gastric emptying when following standard preoperative fasting guidelines.

The 2 groups in the trial

  • GLP-1

    Individuals currently taking glucagon like peptide receptors who have a surgery scheduled with Cincinnati Children's Hospital same day surgery endocrinology clinic and will receive a point of care gastric ultrasound.

    Treatment: Glucagon-Like Peptide-1 receptor agonists and Point of Care Gastric Ultrasound

  • Control

    Individuals not taking GLP-1 who have a surgery scheduled with Cincinnati Children's Hospital same day surgery or endocrinology clinic and will receive a point of care gastric ultrasound.

    Treatment: Point of Care Gastric Ultrasound

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessment of Gastric Contents in Patients Taking Glucagon-Like Peptide-1 Receptor Agonists: a Prospective Observational Cross-sectional Study
Plain-language title
Ultrasound Checks of Stomach Contents in People Taking GLP-1 MedicinesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06581120, who can take part
Record updated
7 November 2024